SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
Silence Therapeutics stock falls despite lowering lipoprotein levels in a phase II study of zerlasiran likely due to concerns ...
healthday55m
Prevalence of High Total Cholesterol 11.3 Percent in U.S. Adults
The prevalence of high total cholesterol was 11.3 percent among U.S. adults in August 2021 to August 2023, accordin ...